WithdrawnPhase 2NCT00657748
Lithium and Acetate for Canavan Disease
Studying Canavan disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Patrick Aubourg, MD, PhDAssistance Publique - Hôpitaux de Paris
- Intervention
- Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)(drug)
- Eligibility
- 1-15 years · All sexes
- Timeline
- 2009 – 2011
Collaborators
European Leukodystrophy Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00657748 on ClinicalTrials.govOther trials for Canavan disease
Additional recruiting or active studies for the same condition.